As of Oct 20
| +0.30 / +0.57%|
The 13 analysts offering 12-month price forecasts for Metlife have a median target of 55.00, with a high estimate of 60.00 and a low estimate of 41.88. The median estimate represents a +3.21% increase from the last price of 53.29.
The current consensus among 16 polled investment analysts is to Buy stock in Metlife. This rating has held steady since October, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.